Silvana F. Capalbo

Foggia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.

Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.

Journal: Cancer

Published: October 20, 2020

Parachute mitral valve assessed by cardiac magnetic resonance.

Parachute mitral valve assessed by cardiac magnetic resonance.

Journal: Interventional medicine & applied science

Published: March 10, 2020

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.

Journal: Haematologica

Published: February 27, 2020

Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib.

Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib.

Journal: Heart failure reviews

Published: February 07, 2020

Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP).

Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP).

Journal: Annals of hematology

Published: January 21, 2020

Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'.

Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'.

Journal: Leukemia & lymphoma

Published: July 10, 2019

Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.

Health-related quality of life in patients with chronic myeloid leukemia receiving first-line therapy with nilotinib.

Journal: Cancer

Published: October 30, 2017

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).

Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).

Journal: Annals of hematology

Published: June 12, 2017

Recovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine.

Recovering from chronic myeloid leukemia: the patients' perspective seen through the lens of narrative medicine.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: May 30, 2017

Ruxolitinib - better prognostic impact in low-intermediate 1 risk score: evaluation of the 'rete ematologica pugliese' (REP) in primary and secondary myelofibrosis.

Ruxolitinib - better prognostic impact in low-intermediate 1 risk score: evaluation of the 'rete ematologica pugliese' (REP) in primary and secondary myelofibrosis.

Journal: Leukemia & lymphoma

Published: June 07, 2016

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.

Nilotinib 300 mg twice daily: an academic single-arm study of newly diagnosed chronic phase chronic myeloid leukemia patients.

Journal: Haematologica

Published: February 23, 2016

Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.

Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: January 31, 2016

Showing 1-12 of 20

Last Updated: 09/26/2026